Back to Pediatrics
Pediatricsv2021 SchutzmanEvidence-Based

Infant Scalp Score

Assesses risk of traumatic brain injury in infants with asymptomatic head injury and isolated scalp hematoma. The Infant Scalp Score (ISS) is a validated clinical tool specifically designed for infants ≤12 months old who present with isolated scalp hematoma after head trauma but are otherwise asymptomatic. The score stratifies risk for clinically important traumatic brain injury (ciTBI) or TBI on computed tomography (CT) to help guide clinical decision-making. This tool is particularly valuable in the pediatric emergency setting where infants are difficult to assess clinically and are most sensitive to ionizing radiation effects. The score considers patient age, hematoma size, and location to calculate risk, helping clinicians determine which infants require neuroimaging versus those who can be safely observed.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Infant Scalp Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Age points (0-3) + Hematoma size points (0-3) + Hematoma location points (0-2)

Clinical Pearls & Practice Notes

  • Validated for infants ≤12 months old with isolated scalp hematoma after head trauma
  • Only for use in asymptomatic infants (no loss of consciousness, seizures, mental status changes)
  • NOT for use in suspected non-accidental trauma cases
  • Score ≥4 indicates high risk and strong consideration for CT imaging
  • Score <4 indicates low risk where clinical observation may be appropriate
  • Some studies suggest ≥5 as cutoff for clinically important TBI
  • Helps avoid unnecessary radiation exposure in low-risk infants
  • Temporal/parietal hematomas carry highest risk (2 points)
  • Younger age groups have progressively higher point values
  • Large boggy hematomas indicate significant force and carry highest size points
  • Tool assists in shared decision-making with families
  • Should be used in conjunction with clinical judgment and PECARN guidelines
  • Particularly valuable when clinical assessment is challenging in infants
  • Validated against clinically important TBI and TBI on CT imaging

Evidence & Literature Citations

  1. Schutzman SA, Nigrovic LE, Mannix R, et al. The Infant Scalp Score: A Validated Tool to Stratify Risk of Traumatic Brain Injury in Infants With Isolated Scalp Hematoma. Acad Emerg Med. 2021;28(1):16-24. doi: 10.1111/acem.14087.
  2. Kuppermann N, Holmes JF, Dayan PS, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009;374(9696):1160-1170. doi: 10.1016/S0140-6736(09)61558-0.
  3. Greenberg JK, Jeffe DB, Carpenter CR, et al. North American Survey of the Management of Minor Head Injury in Children. J Trauma Acute Care Surg. 2018;84(4):613-619. doi: 10.1097/TA.0000000000001808.

Score Interpretation Ranges

Low Risk0 – 3 pts

Score 0-3 points

High Risk4 – 8 pts

Score 4-8 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.